In type II respiratory failure there is:
**Core Concept**
Type II respiratory failure is characterized by **alveolar hypoventilation**, leading to inadequate gas exchange. This results in **hypercapnia** (elevated CO2 levels) and often **hypoxemia** (low O2 levels). The underlying cause is typically related to **neuromuscular** or **chest wall disorders**.
**Why the Correct Answer is Right**
Although the specific correct answer choice is missing, in type II respiratory failure, there is typically an increase in PaCO2 (partial pressure of carbon dioxide) due to decreased ventilation. This is often accompanied by a decrease in PaO2 (partial pressure of oxygen). The **hypercapnia** is a direct result of the **hypoventilation**, which can be caused by various factors including **opioid overdose**, **neuromuscular diseases**, or **chest wall deformities**.
**Why Each Wrong Option is Incorrect**
**Option A:** Without the specific text, it's challenging to address each option directly, but generally, any option that does not acknowledge **hypercapnia** as a key feature of type II respiratory failure would be incorrect.
**Option B:** Similarly, any option failing to recognize the role of **hypoventilation** in the pathogenesis of type II respiratory failure would be wrong.
**Option C:** And any option that does not consider the potential for **hypoxemia** alongside hypercapnia would also be incorrect.
**Option D:** This would be incorrect if it does not align with the pathophysiological characteristics of type II respiratory failure.
**Clinical Pearl / High-Yield Fact**
A key point to remember is that type II respiratory failure involves both **hypercapnia** and often **hypoxemia**, distinguishing it from type I, which is characterized by hypoxemia alone. The treatment typically involves addressing the underlying cause and providing **mechanical ventilation** support when necessary.
**Correct Answer:** Not provided in the query.